Back to User profile » Dr Haya Ascher-Svanum

Papers published by Dr Haya Ascher-Svanum:


Does participation in a weight control program also improve clinical and functional outcomes for Chinese patients with schizophrenia treated with olanzapine?

Montgomery W, Treuer T, Ye W, Xue HB, Wu SH, Liu L, Kadziola Z, Stensland MD, Ascher-Svanum H

Neuropsychiatric Disease and Treatment 2014, 10:1287-1296

Published Date: 10 July 2014

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H

Neuropsychiatric Disease and Treatment 2014, 10:1125-1131

Published Date: 20 June 2014

Movement disorder profile and treatment outcomes in a one-year study of patients with schizophrenia

Chen L, Ascher-Svanum H, Lawson A, Stauffer VL, Nyhuis A, Haynes V, Schuh K, Kinon BJ

Neuropsychiatric Disease and Treatment 2013, 9:815-822

Published Date: 14 June 2013

Validation of a patient interview for assessing reasons for antipsychotic discontinuation and continuation

Matza LS, Phillips GA, Revicki DA, Ascher-Svanum H, Malley KG, Palsgrove AC, Faries DE, Stauffer V, Kinon BJ, Awad AG, Keefe RS, Naber D

Patient Preference and Adherence 2012, 6:521-532

Published Date: 13 July 2012

Reasons for continuing or discontinuing olanzapine in the treatment of schizophrenia from the perspectives of patients and clinicians

Chen J, Ascher-Svanum H, Nyhuis AW, Case MG, Phillips GA, Schuh KJ, Hoffmann VP

Patient Preference and Adherence 2011, 5:547-554

Published Date: 3 November 2011